跳至主要内容
临床试验/CTRI/2024/07/070338
CTRI/2024/07/070338尚未招募不适用

Significance of arterial lactate levels as a mortality indicator in sepsis patients.

Raja Rajeswari Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2024年7月29日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
To determine the association of initial arterial lactate level and thirtyth day outcome in patients with sepsis

研究概览

简要总结

Sepsis is the leading cause of morbidity and mortality and the second commonest cause of death worldwide. Raised blood lactate levels in severe sepsis and septic shock usually indicate impaired oxidative phosphorylation secondary to reduced oxygen availability to the cells (hypoxic hypoxia) and/or tissue hypoperfusion (stagnant hypoxia). Because blood lactate levels can be measured easily and quickly, these have been used as a predictor of tissue hypoperfusion in critically ill patients admitted to the intensive care unit (ICU). Systematic studies on arterial lactate and lactate clearance are lacking in the Indian subpopulation with sepsis. In the present study, we aim to determine association of arterial lactate and lactate clearance and 30th day mortality in patients with sepsis

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with sepsis admitted to ICU.

排除标准

  • Patients/legally responsible relatives of patient refusal to participate in study, unable to do sixth hour follow up for lactate levels, initial lactate less than 2 mmol per litre,history of major surgery,polytrauma,HIV,malignancy,pregnancy,patients taking biguanides or salicylates.

结局指标

主要结局

To determine the association of initial arterial lactate level and thirtyth day outcome in patients with sepsis

时间窗: day 1 and day30

次要结局

  • to determine the association of arterial lactate clearance and thirtyth day outcome in septic patients
  • to compare the association between initial arterial lactate level and lactate clearance with thirtyth day mortality in patients with sepsis(day1 and day30)

研究者

发起方
Raja Rajeswari Medical College and Hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Sowmya M J

Rajarajeswari medical college and hospital

研究点 (1)

Loading locations...

相似试验